user

A US Food and Drug Administration perspective on evaluating medical products for Ebola

被引：9
|
作者：
Russek-Cohen, Estelle [1 ]
Rubin, Daniel [2 ]
Price, Dionne [2 ]
Sun, Wellington [1 ]
Cox, Edward [2 ]
Borio, Luciana [3 ]
机构：
[1] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[3] US FDA, Off Commissioner, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
来源：
CLINICAL TRIALS | 2016年 / 13卷 / 01期
关键词：
Therapeutic clinical trials; vaccine clinical trials; Ebola; SIERRA-LEONE; VACCINE; TRIALS;
D O I：
10.1177/1740774515620613
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：105 / 109
页数：5
相关论文
共 50 条
  • [1] Perspective of the US Food and Drug Administration on concomitant administration of Zostavax and Pneumovax
    Baylor, Norman W.
    [J]. VACCINE, 2011, 29 (48) : 8771 - 8771
  • [2] Adverse drug events in children: The US food and drug administration perspective
    Rodriguez, W
    Roberts, R
    Murphy, D
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (10): : 711 - 723
  • [3] US food and drug administration perspective on aquaculture drug residues.
    Oriani, JA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U50 - U51
  • [4] US Food and Drug Administration's perspective on aquaculture drug residues
    Oriani, JA
    [J]. XENOBIOTICS IN FISH, 1999, : 15 - 23
  • [5] The food and drug administration perspective: Use of an investigational drug in a medical emergency
    Schultheis, Lex W.
    Rappaport, Bob A.
    [J]. ANESTHESIA AND ANALGESIA, 2007, 104 (03): : 479 - 480
  • [6] The US food and drug administration perspective on cancer biomarker development
    Gutman, Steven
    Kessler, Larry G.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (07) : 565 - 571
  • [7] The US Food and Drug Administration perspective on cancer biomarker development
    Steven Gutman
    Larry G. Kessler
    [J]. Nature Reviews Cancer, 2006, 6 : 565 - 571
  • [8] US Food and Drug Administration and regulation of medical devices in radiology
    Pritchard, WF
    Carey, RF
    [J]. RADIOLOGY, 1997, 205 (01) : 27 - 36
  • [9] Risk management of drug products and the US Food and Drug Administration: Evolution and context
    Leiderman, Deborah B.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2009, 105 : S9 - S13
  • [10] Blueprint for Transparency at the US Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products
    Sharfstein, Joshua M.
    Miller, James Dabney
    Davis, Anna L.
    Ross, Joseph S.
    McCarthy, Margaret E.
    Smith, Brian
    Chaudhry, Anam
    Alexander, G. Caleb
    Kesselheim, Aaron S.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 7 - 23
12345